Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders.
Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders.
复制标题
DOI:
10.1038/onc.2015.364
复制
发表时间:
2016-06-09
期刊:
影响因子:
8
通讯作者:
Gartenhaus RB
中科院分区:
文献类型:
--
作者:
Dai B;Chen AY;Corkum CP;Peroutka RJ;Landon A;Houng S;Muniandy PA;Zhang Y;Lehrmann E;Mazan-Mamczarz K;Steinhardt J;Shlyak M;Chen QC;Becker KG;Livak F;Michalak TI;Talwani R;Gartenhaus RB
B-cell receptor (BCR) signaling is essential for the development of B cells and has a critical role in B-cell neoplasia. Increasing evidence indicates an association between chronic hepatitis C virus (HCV) infection and B-cell lymphoma, however, the mechanisms by which HCV causes B-cell lymphoproliferative disorder are still unclear. Herein, we demonstrate the expression of HCV viral proteins in B cells of HCV-infected patients and show that HCV upregulates BCR signaling in human primary B cells. HCV nonstructural protein NS3/4A interacts with CHK2 and downregulates its activity, modulating HuR posttranscriptional regulation of a network of target mRNAs associated with B-cell lymphoproliferative disorders. Interestingly, the BCR signaling pathway was found to have the largest number of transcripts with increased association with HuR and was upregulated by NS3/4A. Our study reveals a previously unidentified role of NS3/4A in regulation of host BCR signaling during HCV infection, contributing to a better understanding of the molecular mechanisms underlying HCV-associated B-cell lymphoproliferative disorders.